Vision
To develop AI/LLM and blockchain business bringing healthcare to the next level.
Business Lines
hashPeak has three business lines: AI/LLM, Web3/Blockahin and Consulting in the healthcare arena and aims to realize the next generation of healthcare.
Corporate Name and Logo
The corporate name, “hashPeak”, consists of “hash” and “Peak”. “hash” is named after one of the cryptographic technologies used in blockchain. “Peak” literally means a peak or a summit.
The three curves beneath the corporate name represent three peaks across the mountain ranges, where hashPeak envisions to lead the world in blockchain, AI/ML and consulting in the healthcare and medical fields.
History
| Jan 2019 | hashPeak founded |
| Nov 2019 | Published the Japanese edition of “Blockchain in Healthcare” by HIMSS from Nikkei BP |
| Apr 2020 | Started the project PCORP (Patient-Centric Open Research Platform) |
| Oct 2020 | Developed and released the demo machine of medical blockchain platform |
| Nov 2020 | Conducted a COVID-19 R&D research for the Cabinet of Japan, reported in the 25th expert committee of the office of National Healthcare Policy Secretariat |
| Dec 2020 | Submitted a patent application on medical blockchain |
| Feb 2021 | Enrolled in Japan Blockchain Association as a silver member |
| Jun 2021 | Conducted a COVID-19 R&D research for the Cabinet of Japan, reported in the 28th expert committee of the office of National Healthcare Policy Secretariat |
| Jul 2021 | Started a new project with blockchain and AI (on-going) |
| Nov 2021 | Conducted a COVID-19 R&D research for the Cabinet of Japan, reported in the 29th expert committee of the office of National Healthcare Policy Secretariat |
| Jan 2022 | AI in healthcare business launched |
| Feb 2022 | Submitted a patent application on medical blockchain |
| Jun 2022 | ISO/IEC27001:2013, JIS Q 27001:2014 Certified |
| Dec 2022 | Submitted a patent application on medical blockchain |
| Apr 2023 | HQ moved to Nihonbashihoncho, Chuo-ku, Tokyo |
| Apr 2024 | Submitted a patent application on generative AI for clinical trial documents |
| Spt 2024 | Launched the beta version of Generative AI Web app for clinical trial documents |
Founder Profile
Takuma Maeda, the founder, has:
- Over 25 years of top management consulting experience with roughly 90 projects for about 60 companies, including those at Arthur D. Little, and IMS Consulting Group
- Over 10 years of healthcare industry experience including at IQVIA Solutions Japan K.K. and IMS Technology Solutions Inc
- Over 10 years of technology experience including as an engineer at Yokogawa Electric Co. and as an executive at IQVIA Solutions Japan K.K.
- Over 20 years of teaching experience at Graduate School of Management, Globis University in Tokyo since 2003
He was awarded an MBA from Tepper School of Management (ex-GSIA), Carnegie Mellon University in the US and a BS in Physics from Keio University in Tokyo, Japan.
He also completed the executive education for AI in Healthcare at Harvard Medical School.
Further details of his experience are as follows:
- Publications
- Translated “Blockchain in Healthcare” by Metcalf et al, Nikkei BP Nov 2019
- Japan Association for Medical Informatics, “Evaluation of automatic vigilance system (AVS) for detecting adverse drug reactions from electronic medical records.” Nov 22, 2017
- TechTarget Japan “Four things that next generation CIO should do ~ Breathe new life in pharma IT” Apr 25, 2017
- Kokusai Iyakuhin Joho “Pharma and Big Data” Apr 11, 25, May 9, 2016
- Co-authored “Globis MBA Management Book II”, Diamond 2015
- Authored “Strategic Implication of Wine”, Toyokeizai 2010
- Translated “Managing Technology for Corporate Success” by Chris Floyd, Eiji 2008
- Conferences
- Globis Pharmaceutical Business Society, “Medical Blockchain”, Jun 2023
- VMO 10th Anniversary in Hanoi：”10-year survival rate of companies” Aug 2022
- ISPOR Singapore: “Evidence Generation based on Blockchain Network”, Sep 2021
- Institution for Corporate Value Maximization: “Medical Blockchain”, Apr 2021
- Globis IP Society, “R&D and IP Trend of Pharmaceutical Industry”, Dec 2020
- Asatte Conference, Globis Management School, “How blockchain would change the world with Covid-19”, July 2020
- Globis Pharmaceutical Business Society, “Medical Blockchain”, Jun 2020
- Seed Planning, “HEOR and Blockchain”, Oct 2019
- Nikkei xTech, “Blockchain in Healthcare”, Oct 2019
- IQVIA Client Conference, “New trend of digital health app and its health economics”, Jul 2018
- Pricing and Market Access Conference in London, “Update on PMA Trends in Japan”, Jun 2016
- Healthcare IT Conference 2016 Speaker “Medical Big Data Strategy of Pharma Companies” Apr 2016
- IMS Client Conference, “New business model that connects healthcare and patients through IT”, Jul 2014
- Articles
- Yodosha: “How will AI & blockchain change medical studies? “, Apr 2023
- JB Press, “Impact of Blockchain disrupting the common sense of the healthcare industry”, Jan 2021
- Monthly Mix, “Future Healthcare brought by Blockchain”, Nov, Dec 2019, Jan, Feb, Mar 2020
- JB Press Special Talk “Real World Data Application Frontline: Medical Transformation in the era of Big Data” Nov 2017
- JB Press Special Talk “Real World Data Application Frontline: RWD advancing Next Generation Medical ICT” Aug 2016
- JB Press Interview “Dawn of Patient Centric Healthcare Business Model” Mar 2014
- Consulting experience by industry
- Pharmaceutical/Life Science
- Engineering
- Electronics/Electric
- Chemical
- Machinery
- Food & Beverage
- Office Equipment
Please feel free to contact: info@hashpeak.com for further information.